Adjuvant Treatment for High-Risk Clear Cell Kidney Cancer

This updated analysis of a subset in the ASSURE clinical trial examines the disease-free survival and overall survival of high-risk patients with clear cell renal cancer treated with sunitinib, sorafenib, or placebo.

http://ift.tt/2mL6oih